Multidimensional characterization of the physiological and behavioral effects of TCB-2 in mice
Mizuki Yamamoto, Hiroto Inoue, Kazuko Hayashi, Illia Aota, Jumpei Matsumoto, Kota Yamada, Koji Toda
bioRxiv August 6, 2026 preprint DOI: 10.64898/2026.08.01.742216 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study |
|---|---|
| Population | Mice |
| Interventions | TCB-2 Volinanserin |
| Key findings | TCB-2 caused pupil constriction and reduced locomotion and licking while preserving the temporal pattern of conditioned licking; volinanserin only partially attenuated some effects, leaving receptor mechanisms unclear. The authors propose that combining automated head-twitch detection with physiological and task measures provides a broader framework for comparing serotonergic compounds. |
Abstract
Background and Purpose Serotonergic psychedelics affect behavior and physiology, but the relationships among these effects remain poorly understood. In rodents, the head-twitch response is used as a measure of psychedelic-like activity, yet it does not capture changes in physiological state or the performance of learned behaviors. Here, we investigated the acute effects of the 5-HT2A receptor agonist TCB-2 across several behavioral and physiological measures and examined how these effects were modified by pretreatment with the 5-HT2A receptor antagonist volinanserin. Experimental Approach Mice were tested in head-fixed and freely moving conditions. During a learned auditory trace-conditioning task, we measured licking, pupil area, eye position, and blinking. We measured locomotor activity in an open field and quantified head-twitch responses using a DeepLabCut-based method. To examine the contribution of 5-HT2A receptors, mice were pretreated with the 5-HT2A receptor antagonist volinanserin. Key Results TCB-2 caused pupil constriction without detectable changes in eye position or blinking when administered alone. TCB-2 also reduced licking at the highest dose, but the cue-locked temporal pattern of licking remained evident. In freely moving mice, TCB-2 reduced locomotor activity and produced a dose-dependent increase in head-twitch responses. Volinanserin partially attenuated TCB-2-induced pupil constriction and reduced head-twitch responses under some conditions, but it did not consistently prevent the other effects of TCB-2. Conclusions and Implications TCB-2 produced distinct effects across physiological and behavioral measures rather than a uniform disruption of behavioral function. Pronounced pupil constriction and head-twitch responses occurred without detectable changes in eye position or blinking, while the temporal organization of conditioned licking was retained despite a reduction in its magnitude. The incomplete and variable effects of volinanserin preclude definitive conclusions about the receptor mechanisms underlying each response. Combining automated head-twitch detection with physiological and task-related measurements provides a broader framework for comparing the pharmacological profiles of serotonergic compounds. What is already known Classical psychedelics produce characteristic effects primarily through serotonin 5-HT2A receptor activation. Head-twitch responses capture only one dimension of psychedelic-like drug action. What this study adds TCB-2 reduced locomotion and licking while preserving the cue-locked pattern of conditioned licking. Pupil constriction occurred without detectable changes in eye position or blinking. Clinical significance Multidimensional phenotyping can distinguish the physiological and behavioral profiles of serotonergic compounds. Complementary measures may improve preclinical evaluation of emerging serotonergic therapeutics.